Table 5.
Vaccinea | n | ELISA Ab titer at 60 dpv | Bovines |
Guinea pig | |||||
---|---|---|---|---|---|---|---|---|---|
Virus shedding |
Clinical signs |
ELISA ab titer at 30 dpv | |||||||
Peak of infectious virus titer (TCID50/ml) | Duration of virus shedding (days) | AUCib | Rhinitys severity | Duration (days) | AUCsc | ||||
1 | 6 | 3.76Ad | 2.4C | 2.3B | 6.2C | 1.5B | 11A | 15.7A | 3.1A |
2 | 6 | 2.6B | 5.0B | 6.7A | 22.2B | 1.9AB | 12A | 20. 6A | 2.7A |
Placebo | 9 | 0.3C | 6.9A | 7.1A | 34.7A | 2.5A | 14A | 33.8B | 0.3B |
Vaccines previously classified by the guinea pig model and the host species as “very satisfactory” (1) and “satisfactory” (2).
AUCi area under the curve obtained by plotting the virus titer shed during 14 days after challenge.
AUCs area under the curve obtained by plotting the severity of the disease registered during 14 days after challenge.
Mean in the same column with different uppercase letters, indicates significant differences as determined by one-way ANOVA, p < 0.05.